| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.43 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |